2osl: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "2osl" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 24: | Line 24: | ||
*[[Antibody]] | *[[Antibody]] | ||
*[[Monoclonal Antibody]] | *[[Monoclonal Antibody]] | ||
*[[Rituximab]] | |||
==Reference== | ==Reference== | ||
Revision as of 13:14, 28 December 2010
| |||||||||||||
| 2osl, resolution 2.60Å (default scene) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||
| |||||||||||||
| Resources: | FirstGlance, OCA, RCSB, PDBsum | ||||||||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||||||||
Crystal structure of Rituximab Fab in complex with an epitope peptide
Template:ABSTRACT PUBMED 17395584
About this Structure
2osl is a 6 chain structure of Antibody and Monoclonal Antibody with sequence from Homo sapiens, mus musculus. Full crystallographic information is available from OCA.
See Also
Reference
- Du J, Wang H, Zhong C, Peng B, Zhang M, Li B, Huo S, Guo Y, Ding J. Structural basis for recognition of CD20 by therapeutic antibody Rituximab. J Biol Chem. 2007 May 18;282(20):15073-80. Epub 2007 Mar 29. PMID:17395584 doi:10.1074/jbc.M701654200
